Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in-vitro fertilization
Yh. Lam et al., Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in-vitro fertilization, HUM REPR, 14(8), 1999, pp. 2120-2123
Data in the Caucasian population suggest that maternal serum alpha-fetoprot
ein (AFP) and unconjugated oestriol concentrations are reduced and human ch
orionic gonadotrophin (HCG) concentrations are elevated in pregnancies conc
eived after in-vitro fertilization (IVF), leading to a higher than expected
Down's syndrome screen-positive rate. There are no previous reports on the
serum marker values in pregnancies conceived after intracytoplasmic inject
ion (ICSI), Between 1996 and 1998, we measured maternal serum total HCG and
AFP concentrations between 15 and 20 weeks gestation in 42 in-vitro fertil
ization (IVF) pregnancies and 23 ICSI pregnancies with known normal outcome
. The results were compared with that of 2799 naturally occurring singleton
pregnancies who were known to have a normal outcome. Median AFP multiple o
f the median (MOM) in ICSI pregnancies was significantly reduced to 0.76 co
mpared with both that of the controls and that of the IVF pregnancies. For
the IVF pregnancies, median HCG MOM was elevated to 1.15, and median AFP MO
M was reduced to 0.88 compared with the controls, but these differences wer
e not statistically significant, In both the IVF and ICSI pregnancies the c
hanges might result in a falsely high Down's syndrome risk. In particular,
the reduced AFP concentration in ICSI pregnancies was substantial. If this
preliminary finding is substantiated by other series, the appropriate adjus
tment needs to be made to allow for valid interpretation of the screen resu
lt and to avoid an unnecessarily high false positive rate.